Lung Cancer News

In this edition, recurrence-free survival estimates in less advanced lung cancer, bronchoscopy-guided microwave ablation safe in lung abnormality and more.

The FDA released results from its investigation of benzene in acne products containing benzoyl peroxide. In light of these findings, the American Academy of Dermatology updated its statement on benzoyl peroxide in personal care products.

Among patients with non-small cell lung cancer treated with resection surgery, those classified as stage I vs. stage III had higher recurrence-free survival estimates 5 years after the procedure, according to results published in CHEST.

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.

Older adults with cancer had a lower risk for Alzheimer’s disease and related dementias than cancer-free individuals of the same age, according to results of a longitudinal retrospective study.

The safety of three therapeutic methods, each featuring electromagnetic navigation bronchoscopy-guided microwave ablation, was established in patients with multiple bilateral ground-glass opacities, according to study results.

High muscle strength and cardiorespiratory fitness reduced mortality for people diagnosed with cancer, according to a systematic review and meta-analysis.

Concomitant use of statins improved survival among people with cancer treated with immune checkpoint inhibitors, according to results of a meta-analysis.

An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune checkpoint inhibitors.